Andrew Ambrosy to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Andrew Ambrosy has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.143
-
The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol. 2013 Feb; 10(2):85-97.
Score: 0.112
-
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J. 2014 Aug; 168(2):142-9.
Score: 0.031